tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

JNJ Stock Latest News

Why Johnson & Johnson Stock (JNJ) is Poised for Higher Highs in Q4
Market NewsWhy Johnson & Johnson Stock (JNJ) is Poised for Higher Highs in Q4
1d ago
JNJ
Johnson & Johnson recommends shareholders reject Tutanota mini tender offer
PremiumThe Fly
Johnson & Johnson recommends shareholders reject Tutanota mini tender offer
1d ago
JNJ
Trump Weekly: Generics to be excluded from pharma tariff plan
PremiumThe Fly
Trump Weekly: Generics to be excluded from pharma tariff plan
1d ago
C
ES
M&A News: Protagonist Therapeutics Stock (PTGX) is Star of the Show on JNJ Bid Talk
PremiumMarket News
M&A News: Protagonist Therapeutics Stock (PTGX) is Star of the Show on JNJ Bid Talk
1d ago
JNJ
PTGX
Midday Fly By: Trump threatens China tariffs, Kalshi valued at $5B
PremiumThe Fly
Midday Fly By: Trump threatens China tariffs, Kalshi valued at $5B
1d ago
MS
VG
Protagonist Therapeutics resumes, up 28% after report of J&J takeover talks
PremiumThe FlyProtagonist Therapeutics resumes, up 28% after report of J&J takeover talks
1d ago
JNJ
PTGX
Is Johnson & Johnson Stock (JNJ) a Buy Ahead of Q3 Earnings?
Premium
Market News
Is Johnson & Johnson Stock (JNJ) a Buy Ahead of Q3 Earnings?
1d ago
JNJ
PFE
J&J in talks to buy Protagonist Therapeutics, WSJ reports
Premium
The Fly
J&J in talks to buy Protagonist Therapeutics, WSJ reports
1d ago
JNJ
PTGX
Protagonist Therapeutics jumps 9%, halted after WSJ report on J&J takeover talks
PremiumThe Fly
Protagonist Therapeutics jumps 9%, halted after WSJ report on J&J takeover talks
1d ago
JNJ
PTGX
Johnson & Johnson in talks to buy Protagonist Therapeutics, WSJ reports
PremiumThe Fly
Johnson & Johnson in talks to buy Protagonist Therapeutics, WSJ reports
1d ago
JNJ
PTGX
Trump Trade: GoodRx, others in talks with White House to join TrumpRx
PremiumThe Fly
Trump Trade: GoodRx, others in talks with White House to join TrumpRx
2d ago
AZN
BMY
Johnson & Johnson price target raised to $209 from $185 at RBC Capital
PremiumThe Fly
Johnson & Johnson price target raised to $209 from $185 at RBC Capital
2d ago
JNJ
Johnson & Johnson price target raised to $178 from $176 at Morgan Stanley
PremiumThe FlyJohnson & Johnson price target raised to $178 from $176 at Morgan Stanley
2d ago
JNJ
GoodRx, others in talks with White House to join TrumpRx, Reuters reports
Premium
The Fly
GoodRx, others in talks with White House to join TrumpRx, Reuters reports
2d ago
AZN
BMY
Trump Trade: Generics to be excluded from pharma tariff plan
Premium
The Fly
Trump Trade: Generics to be excluded from pharma tariff plan
3d ago
AZN
BMY
Generics to be excluded from Trump’s pharma tariff plan, WSJ reports
PremiumThe Fly
Generics to be excluded from Trump’s pharma tariff plan, WSJ reports
3d ago
AZN
BMY
Balanced Outlook for Johnson & Johnson: Hold Rating Amid Stable Revenue and Slight EPS Decline
PremiumRatings
Balanced Outlook for Johnson & Johnson: Hold Rating Amid Stable Revenue and Slight EPS Decline
4d ago
JNJ
Protagonist Therapeutics price target raised to $74 from $62 at Clear Street
PremiumThe Fly
Protagonist Therapeutics price target raised to $74 from $62 at Clear Street
4d ago
JNJ
PTGX
IBM partners with Anthropic, Dell boosts long-term view: Morning Buzz
PremiumThe Fly
IBM partners with Anthropic, Dell boosts long-term view: Morning Buzz
4d ago
C
F
Jury awards $966M in talc verdict against Johnson & Johnson, Law.com reports
PremiumThe FlyJury awards $966M in talc verdict against Johnson & Johnson, Law.com reports
4d ago
JNJ
Johnson & Johnson’s icotrokinra meets primary endpoint in ulcerative colitis
Premium
The Fly
Johnson & Johnson’s icotrokinra meets primary endpoint in ulcerative colitis
5d ago
JNJ
Johnson & Johnson’s Acuvue contact lens shows efficacy in studies
Premium
The Fly
Johnson & Johnson’s Acuvue contact lens shows efficacy in studies
5d ago
JNJ

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >